tirzepatide uspi FullScopeMD like peptide Tirzepatide - Metabolic / GLP

The most common user-reported experience: Temporary skin dryness in week 1 (resolves by week 2) Occasional injection site redness (standard for any subQ peptide) Some users report increased hair growth, including in unintended areas at higher doses At doses above 34 mg/day, some protocols note headaches, but this is well above standard dosing

Tirzepatide: Dual GLP-1/GIP Agonist Tirzepatide activates two receptor types simultaneously: GLP-1 (Glucagon-like peptide-1): Slows gastric emptying, reduces appetite, and enhances insulin secretion GIP (Glucose-dependent insulinotropic polypeptide): Improves insulin sensitivity and may have direct effects on fat tissue Retatrutide: Triple GLP-1/GIP/Glucagon Agonist Retatrutide includes everything tirzepatide does, plus a third target: GLP-1: Same appetite suppression and insulin benefits GIP: Same metabolic and insulin sensitizing effects Glucagon receptor: Increases energy expenditure, promotes fat oxidation, and may help preserve lean muscle mass Why Glucagon Matters Glucagon shifts the body toward burning stored fat for energy and increases metabolic rate

What surprised me most wasnt the weight loss it was the ripple effect on my meal planning

While I understand that this action may concern some people, the risk of not acting is far greater, Minister Butler stated

If NICE recommends them in future, access would likely follow similar criteria to Wegovy injections requiring referral through a specialist weight management service, strict BMI thresholds, and evidence that other weight loss approaches have already been tried